✦ LIBER ✦

Tu2107 Immunomodulation for Treatment of Drug and Device Refractory Gastroparesis: An Open Label Pilot Study of GAD65 Positive Patients

✍ Scribed by Kedar, Archana; Nikitina, Yana; Martin, Evelyn; Vedanarayanan, Vetta; Abell, Thomas L.

Book ID: 122840432
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 316 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)63462-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Extracorporeal photopheresis for the tre

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: Results of an open-label pilot study

✍ Maria T. Abreu; Christian von Tirpitz; Robert Hardi; Martin Kaatz; Gert Van Assc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 2 views

## Background: Extracorporeal photopheresis (ecp) is effective in immune-mediated disorders. a prospective, uncontrolled pilot study was conducted to evaluate the safety and efficacy of ecp in patients with active crohn's disease (cd) who were refractory to or intolerant of immunosuppressants and/o

An open-label pilot study of the effecti

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

✍ Arie E. van der Bijl; Ferdinand C. Breedveld; Christian E. Antoni; Joachim R. Ka 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 182 KB

2129 POSTER An open-label study of capec

2129 POSTER An open-label study of capecitabine (C) and docetaxel (D) as neoadjuvant treatment for patients with recently diagnosed HER2-neu negative (HER2–) breast cancer (BC) plus trastuzumab (T) for HER2-neu positive (HER2+) BC

✍ D. Tripathy; C. Moisa; S. Glück 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB